| | | | | (Reuters) - Johnson & Johnson suffered its first trial loss in a lawsuit claiming its talc-based products including Johnson's Baby Powder contain cancer-causing asbestos, with a New Jersey jury on Thursday ordering J&J and another company to pay $37 million in damages. | | |
| | | (Reuters) - Medicare, the U.S. government healthcare program for the elderly and disabled, will pay hospitals close to its standard mark-up rate for administering cell therapy Yescarta for cancer outpatients, who will have a co-payment of nearly $80,000, according to the Centers for Medicare & Medicaid Services (CMS). | | |
| | | (Reuters Health) - An experimental smartphone application could monitor changes in Parkinson's disease symptoms throughout the day, sending data to doctors to help them treat patients, U.S. researchers say. | | |
| | | LUSAKA (Reuters) - Zambia has withdrawn military personnel deployed in December to help clean up the capital and other cities at the height of a cholera outbreak that has killed more than 80 people in seven months, the government said on Wednesday. | | |
| | | NEW YORK (Reuters) - JPMorgan Chase & Co, Amazon.com Inc., and Berkshire Hathaway will focus on the biggest health issues threatening the U.S. economy in their new joint venture, including aligning healthcare payments with employee health and addressing chronic diseases, CEO Jamie Dimon said in his annual letter to shareholders. [nL2N1RI0U7] | | |
| | | (Reuters Health) - Children and teens who undergo ostomy surgery now have a resource written by their peers to help them navigate the challenges of middle school, high school, college and beyond. | | |
| | | (Reuters) - AbbVie Inc on Thursday said it signed a deal with Samsung Bioepis and its joint venture partner Biogen Inc that would fend off U.S. competition of their biosimilar version to blockbuster drug Humira until 2023. | | |
| | | SOFIA (Reuters) - Bulgaria's authorities reported an outbreak of the highly pathogenic H5N8 bird flu virus on a duck farm in the southeastern region of Yambol, the food safety agency said on Thursday. | | |
| | | COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk has secured the global licence for U.S. biotech company EpiDestiny's sickle cell disease (SCD) program in a bid to offset declining sales in its biopharmaceutical business. | | |
| | | (Reuters) - Kaleo Inc, which came under fire last year for the high price of its device to treat opioid overdoses, on Thursday said it is expanding nonprescription access to the Evzio injector and will sell it to U.S. government agencies at a steep discount. | | |
|
| |
